IMCGX
Price
$8.34
Change
-$2.91 (-25.87%)
Updated
Feb 3 closing price
Net Assets
133.25M
TRQZX
Price
$98.26
Change
-$6.13 (-5.87%)
Updated
Feb 3 closing price
Net Assets
25.1B
Interact to see
Advertisement

IMCGX vs TRQZX

Header iconIMCGX vs TRQZX Comparison
Open Charts IMCGX vs TRQZXBanner chart's image
Transamerica Mid Cap Growth I
Price$8.34
Change-$2.91 (-25.87%)
VolumeN/A
Net Assets133.25M
T. Rowe Price Mid-Cap Growth Z
Price$98.26
Change-$6.13 (-5.87%)
VolumeN/A
Net Assets25.1B
IMCGX vs TRQZX Comparison Chart in %
View a ticker or compare two or three
VS
IMCGX vs. TRQZX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCGX is a Hold and TRQZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRQZX has more cash in the bank: 25.1B vs. IMCGX (133M). TRQZX pays higher dividends than IMCGX: TRQZX (0.74) vs IMCGX (0.00). IMCGX was incepted earlier than TRQZX: IMCGX (12 years) vs TRQZX (6 years). IMCGX (0.89) is less costly to investors than TRQZX (0.61). IMCGX is a more actively managed with annual turnover of: 109.00 vs. TRQZX (22.60). TRQZX has a lower initial minimum investment than IMCGX: TRQZX (0) vs IMCGX (1000000). TRQZX annual gain was more profitable for investors over the last year : -5.09 vs. IMCGX (-21.98). TRQZX return over 5 years is better than : -13.86 vs. IMCGX (-40.43).
IMCGXTRQZXIMCGX / TRQZX
Total Expense Ratio0.890.00-
Annual Report Gross Expense Ratio0.890.61146%
Fund Existence12 years6 years-
Gain YTD-3.472-0.0615,690%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets133M25.1B1%
Annual Yield % from dividends0.000.74-
Returns for 1 year-21.98-5.09432%
Returns for 3 years8.452.38356%
Returns for 5 years-40.43-13.86292%
Returns for 10 years-13.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFXXF2.010.01
+0.50%
HELIOS FAIRFAX PARTNERS CORP.
MBXBF0.16N/A
N/A
Microbix Biosystems Inc.
TMPRX58.39-0.06
-0.10%
Touchstone Mid Cap R6
GSPUX42.20-0.34
-0.80%
Goldman Sachs Large Cap Equity R6
BRWTX26.98-0.50
-1.82%
MFS Blended Research Growth Eq R3